The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.
Evommune Inc (NYSE:EVMN)
On June 29, Evommune disclosed that its investigational therapy EVO756 failed to meet the primary endpoint in a mid-stage study in patients with chronic spontaneous urticaria (CSU). The update prompted the clinical-stage biotechnology company to discontinue development of the drug candidate for the indication. The company’s stock fell around 46% over the past five days and has a 52-week low of $12.51.
